Aspirion Health Resources, LLC

Aspirion Health Resources, LLC specializes in Revenue Cycle Management (RCM) services, optimizing claims reimbursements for healthcare providers through advanced technology and operational strategies. Founded in 2008 and headquartered in Columbus, US, Aspirion Health Resources, LLC focuses on healthcare revenue optimization. The company experienced strategic growth through the mergers with Specialized Healthcare Partners, LLC in August 2019, and Arx Healthcare in April 2022. In June 2022, the company secured a majority stake acquisition by Linden Capital Partners and Varsity Healthcare Partners for approximately USD 650 mn.

The deal facilitated the retention of a stake in the company by the management team and Aquiline Capital Partners. The CEO is Amy Amick, with Patrick Lutz serving as the Founder. Aspirion has completed a total of 2 deals, with the most recent on June 21, 2022. Aspirion specializes in Revenue Cycle Management (RCM) services that enhance reimbursements from denied and complex healthcare claims.

Core offerings include Denials Management, Out-of-Network Recovery, Payment Variance Recovery, and Complex Claims Management. Supported by the proprietary Compass platform, the company integrates artificial intelligence and automation to streamline workflows and analyze medical records for clinical appeals. Aspirion serves various hospitals and healthcare providers across the U. S.

, recovering over USD 6 billion in claims and enhancing operational efficiency for its clients. Aspirion operates on a performance-based revenue model, partnering with healthcare providers to improve revenue recovery efforts. Revenue is generated through service agreements that may include shared savings or success-based fees from claims recovery. The company has reported recoveries exceeding USD 6 billion, highlighting its effectiveness in the RCM sector.

Following the latest funding round on June 21, 2022, Aspirion plans to utilize the investment to support strategic growth initiatives through advancements in technology and product development, as well as mergers and acquisitions. The company aims to introduce new products and expand into additional U. S. healthcare markets, leveraging the expertise gained from recent mergers to enhance its service offerings and operational capabilities.